Evidence map›Paper›PMID 34185059›Full record

Observational studyInvestigative ophthalmology & visual science2021

Characterization of the Spectrum of Ophthalmic Changes in Patients With Alagille Syndrome.

Mariana Matioli da Palma, Austin D Igelman, Cristy Ku, Amanda Burr, Jia Yue You, Emily M Place, Nan-Kai Wang, Jin Kyun Oh, Kari E Branham, Xinxin Zhang and 18 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Investigative ophthalmology & visual science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Strabismus in Genetic Syndromes: A Review.Clinical & experimental ophthalmology · 2025
    Review
  6. The Role of Visual Electrophysiology in Systemic Hereditary Syndromes.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Management of adults with Alagille syndrome.Hepatology international · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Alagille syndrome due to aFrontiers in pediatrics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 20 institutions in 4 countries.

Mariana Matioli da PalmaCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Austin D IgelmanCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Cristy KuCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Amanda BurrCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Jia Yue YouDepartments of Ophthalmology, Human Genetics, and Pediatric Surgery, Montreal Children's Hospital, McGill University Health Centre, McGill University, Montreal, QC, Canada.
Emily M PlaceDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States.
Nan-Kai WangDepartment of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, United States.
Jin Kyun OhDepartment of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, United States.
Kari E BranhamDepartment of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
Xinxin ZhangDuke Eye Center, Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States.
Jeeyun AhnUCLA Stein Eye Institute, Division of Retinal Disorders and Ophthalmic Genetics, Department of Ophthalmology, David Geffen School of Medicine, UCLA, Los Angeles, California, United States.
Michael B GorinUCLA Stein Eye Institute, Division of Retinal Disorders and Ophthalmic Genetics, Department of Ophthalmology, David Geffen School of Medicine, UCLA, Los Angeles, California, United States.
Byron L LamBascom Palmer Eye Institute, University of Miami, Miami, Florida, United States.
Cecinio C RonquilloJohn A. Moran Eye Center, University of Utah, Salt Lake City, Utah, United States.
Paul S BernsteinJohn A. Moran Eye Center, University of Utah, Salt Lake City, Utah, United States.
Aaron NagielThe Vision Center, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, California, United States.
Rachel HuckfeldtDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States.
Michelle T CabreraDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States.
John P KellyDepartment of Ophthalmology, Seattle Children's Hospital, Seattle, Washington, United States.
Benjamin BakallDepartment of Ophthalmology, University of Arizona College of Medicine, Phoenix, Arizon, United States.
Alessandro IannacconeDuke Eye Center, Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States.
Robert B HufnagelOphthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Wadih M ZeinOphthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Robert K KoenekoopDepartments of Ophthalmology, Human Genetics, and Pediatric Surgery, Montreal Children's Hospital, McGill University Health Centre, McGill University, Montreal, QC, Canada.
David G BirchRetina Foundation of the Southwest, Dallas, Texas, United States.
Paul YangCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Abigail T FahimDepartment of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
Mark E PennesiCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Oregon Health & Science University · USDuke University · USUniversity of Utah · USColumbia University Irving Medical Center · USHarvard University · USMassachusetts Eye and Ear Infirmary · USMcGill University Health Centre · CAMiami Dermatology and Laser Institute · USMichigan United · USMontreal Children's Hospital · CANational Eye Institute · USNational Institutes of Health · USRetina Foundation of the Southwest · USSeattle Children's Hospital · USSeoul National University · KRState University of New York · USUniversidade Federal de São Paulo · BRUniversity of Arizona · USUniversity of California, Los Angeles · USUniversity of Michigan · US

Funding

Vision Research CoreP30EY001730 · NEI · UNIVERSITY OF WASHINGTON · PI Jay Neitz · 1985 to 2026
$23.5M
Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI TED S ACOTT · 1995 to 2026
$19.4M
Genomic and epigenomic mechanisms of pediatric ocular disordersZIAEY000565 · NEI · NATIONAL EYE INSTITUTE · PI HUFNAGEL, ROBERT · 2019 to 2024
$11.4M
MEASURES OF HUMAN RECEPTOR AND POST RECEPTOR ACTIVITYR01EY009076 · NEI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI BIRCH, DAVID G, HOOD, DONALD C. · 1991 to 2021
$8.3M
Michigan Vision Clinician Scientist Development ProgramK12EY022299 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Abigail Fahim, DAVID N ZACKS · 2013 to 2026
$6.3M
Reprogramming the metabolome to overcome the genetic heterogeneity in retinitis pigmentosaR01EY031354 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, NAN-KAI · 2020 to 2024
$2.0M
Neuroprotective Mechanisms of Inosine Monophosphate Dehydrogenase Inhibitors in Retinitis PigmentosaK08EY026650 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI YANG, PAUL · 2016 to 2020
$1.1M
NEI NIH HHS K08 EY026650NEI NIH HHS K12 EY022299NEI NIH HHS P30 EY001730NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY009076NEI NIH HHS R01 EY031354
6 · The paper itself

Abstract

Purpose: The purpose of this study was to characterize the phenotypic spectrum of ophthalmic findings in patients with Alagille syndrome. Methods: We conducted a retrospective, observational, multicenter, study on 46 eyes of 23 subjects with Alagille syndrome. We reviewed systemic and ophthalmologic data extracted from medical records, color fundus photography, fundus autofluorescence, optical coherence tomography, visual fields, electrophysiological assessments, and molecular genetic findings. Results: Cardiovascular abnormalities were found in 83% of all cases (of those, 74% had cardiac murmur), whereas 61% had a positive history of hepatobiliary issues, and musculoskeletal anomalies were present in 61% of all patients. Dysmorphic facies were present in 16 patients, with a broad forehead being the most frequent feature. Ocular symptoms were found in 91%, with peripheral vision loss being the most frequent complaint. Median (range) Snellen visual acuity of all eyes was 20/25 (20/20 to hand motion [HM]). Anterior segment abnormalities were present in 74% of the patients; of those, posterior embryotoxon was the most frequent finding. Abnormalities of the optic disc were found in 52%, and peripheral retinal abnormalities were the most frequent ocular finding in this series, found in 96% of all patients. Fifteen JAG1 mutations were identified in 16 individuals; of those, 6 were novel. Conclusions: This study reports a cohort of patients with Alagille syndrome in which peripheral chorioretinal changes were more frequent than posterior embryotoxon, the most frequent ocular finding according to a number of previous studies. We propose that these peripheral chorioretinal changes are a new hallmark to help diagnose this syndrome.

Indexed as

Eye Diseases, HereditaryOptic DiskRetinaAdultAlagille SyndromeDiagnosis, DifferentialFemaleFluorescein AngiographyGenetic TestingHumansJagged-1 ProteinMaleMedical RecordsMutationOptical ImagingTomography, Optical CoherenceJAG1 protein, humanJagged-1 Protein

Identifiers

PMID34185059
PMCPMC8254011
OpenAlexW3177355743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.